மருந்து ஆராய்ச்சி விஞ்ஞானி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ஆராய்ச்சி விஞ்ஞானி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ஆராய்ச்சி விஞ்ஞானி Today - Breaking & Trending Today

COVID-19: Delta variant remains big threat to Nigeria, experts warn

COVID-19: Delta variant remains big threat to Nigeria, experts warn
The Punch
Public health experts have warned that the delta variant of COVID-19 first detected in India remains a big threat to Nigeria, noting that it could spark a surge of the viral infection that will be difficult to contain.
According to the experts, while the country is vulnerable to a new wave of COVID-19 infection due to low vaccination coverage, the delta variant is of more concern because existing vaccines have not been conclusively proven to be effective against the strain confirmed to be more virulent and more transmissible. ....

Abuja Federal Capital Territory , Taiwo Obembe , Martin Emeje , Tedros Adhanom Ghebreyesus , Research Scientist , Public Health Physician , National Institute For Pharmaceutical Research , Associated Press , World Health Organisation , Pharmaceutical Research Scientist , Yaba Mainland , Sunday Alamba , National Institute , Pharmaceutical Research , கூட்டாட்சியின் மூலதனம் பிரதேசம் , ஆராய்ச்சி விஞ்ஞானி , பொது ஆரோக்கியம் மருத்துவர் , தேசிய நிறுவனம் க்கு மருந்து ஆராய்ச்சி , தொடர்புடையது ப்ரெஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , மருந்து ஆராய்ச்சி விஞ்ஞானி , தேசிய நிறுவனம் , மருந்து ஆராய்ச்சி ,

Why FG may not rush to give Nigerians COVID-19 vaccines —Scientists

Why FG may not rush to give Nigerians COVID-19 vaccines Scientists
Yusuff Moshood
Nigerian scientists say that immunising Nigerians with COVID-19 vaccine when clinical trials have not been done in the country is very risky and should be reconsidered.
They also expressed worries over its likely long-term effects.
Nigeria expects its batch of vaccines by first quarter of 2021, with the Director-General of the National Centre for Disease Control, Dr. Chikwe Ihekweazu, saying that 20 percent of the population would have access to the vaccine.
Speaking on the issue, a virologist at the Lagos University Teaching Hospital, Prof. Sunday Omilabu; and a Pharmaceutical Research Scientist with the National Institute for Pharmaceutical Research and Development, Abuja, Prof. Martin Emeje, are of the view that immunising Nigerians with COVID-19 vaccine when clinical trials were not done in the country is very risky and should be reconsidered. ....

United States , Abuja Federal Capital Territory , Martin Emeje , Yusuff Moshood , National Institute For Pharmaceutical Research , Centre For Human , Drug Administration , University Of Lagos , National Centre For Disease , World Health Organisation , Research Scientist , European Union , European Medicines Agency , Lagos University Teaching Hospital , College Of Medicine , National Centre , Disease Control , Sunday Omilabu , Pharmaceutical Research Scientist , National Institute , Pharmaceutical Research , United States Food , Zoonotic Virology , Nigerians Covid 19 Vaccines , Latest Nigerian News , Nigeria News ,